Streetbeat News

Partnerships

THAR

Tharimmune has established a Scientific Advisory Board comprising leading experts in immunology, liver diseases, protein engineering, and antibody drug conjugates to advance its clinical-stage lead in chronic liver disease and its early-stage tunable knob domains for generating antibody drug conjugate biotherapeutics.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:35 pm

NRXP

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has developed a new, proprietary formulation of IV Ketamine, HTX-100, with a neutral pH, enabling both IV and subcutaneous administration. This development, based on prior patents by NRx's founder, may lead to patent protection and is expected to be marketed by HOPE Therapeutics, a subsidiary of NRx. The formulation was developed in partnership with Nephron Pharmaceuticals and is aimed at modernizing ketamine's use in medicine, potentially through insulin pump-like devices. NRx plans to submit a New Drug Application for HTX-100 for treating suicidal depression.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:34 pm

HTCR

HeartCore Enterprises, Inc. (NASDAQ:HTCR) has signed its 14th Go IPO consulting service agreement with Koei Shoji, expecting to generate $500,000 in initial fees and receiving a warrant to acquire 3% of Koei Shoji's common stock. Despite challenges in the 2023 IPO market, HeartCore's CEO Sumitaka Kanno Yamamoto remains optimistic about the demand for U.S. equity markets among Japanese companies, driven by effective marketing strategies and the depreciated yen. The agreement aims to assist Koei Shoji in going public on Nasdaq or NYSE, with services including audit and legal firm hiring, document translation, and IPO preparation.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:32 pm

MBOT

Microbot Medical Inc. (NASDAQ:MBOT) announced that despite geopolitical tensions in Israel, its regulatory, clinical, operational, and pre-commercial activities remain on track. The company is progressing with its FDA IDE submission for the LIBERTY Endovascular Robotic Surgical System and is preparing for ISO 13485 certification audits for CE approval in Europe. It has also secured sufficient inventory for its pivotal study and is engaging with clinical and strategic partners for future development and commercialization efforts.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:31 pm

ERIC

MEI

XRX

Wall Street's most accurate analysts have provided their views on three high-yielding tech stocks: Xerox Holdings Corporation (XRX), Telefonaktiebolaget LM Ericsson (ERIC), and Methode Electronics, Inc. (MEI). XRX has a dividend yield of 5.93% with mixed analyst ratings and a recent partnership in Peru and Ecuador. ERIC, with a 5.11% yield, received downgrades amid news of its effective anti-corruption compliance program. MEI offers a 4.47% yield, with recent coverage initiations and downgrades, alongside news of its CFO's retirement.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:20 pm

HYMTF

TSLA

Hyundai's IONIQ 5 robotaxi, developed in collaboration with Motional, has passed a simulated driving test, showcasing its autonomous driving capabilities. The test, part of a campaign film, was conducted in Las Vegas and featured a simulation of a U.S. driver's license test. The IONIQ 5 is currently transporting passengers in select areas of Las Vegas via the Uber app, with a vehicle operator present. Meanwhile, Tesla is preparing to unveil its own self-driving robotaxi on August 8, with CEO Elon Musk emphasizing the importance of vehicle autonomy to the company's value.

Portfolio Pulse from Anan Ashraf

April 15, 2024 | 12:16 pm

OPTX

Syntec Optics Holdings, Inc. (NASDAQ:OPTX), a leader in mission-critical optics, announced executive changes to bolster growth. Al Kapoor is appointed Chairman and CEO to lead strategy and potential acquisitions, leveraging his extensive experience. Joe Mohr becomes Chief Manufacturing Officer, focusing on sales, business development, and manufacturing excellence. These changes aim to support organic growth and strategic initiatives for future expansion.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:13 pm

VSTE

Vast Renewables has signed engineering contracts with Afry, FYFE, Primero, and Worley for the front-end engineering design of the VS1 project, a 30MW / 288 MWh CSP plant in Port Augusta, South Australia. The project, leveraging Vast's modular tower CSP v3.0 technology, aims to produce clean, low-cost, dispatchable power and includes over 8 hours of thermal energy storage. It is expected to generate numerous green manufacturing jobs, hundreds of construction jobs, and long-term operational roles.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:10 pm

EQIX

Equinix, Inc. (NASDAQ:EQIX) and PGIM Real Estate have announced a $600 million joint venture to develop and operate the first xScale data center in the U.S., located in Silicon Valley. The facility, named SV12x, will offer over 28 MW of power capacity and is part of Equinix's global xScale data center portfolio, expected to exceed $8 billion and 725 MW across more than 35 facilities. PGIM Real Estate will hold an 80% equity interest, with Equinix holding the remaining 20%. This venture marks PGIM Real Estate's first investment through its global data center strategy.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:09 pm

NGMS

NeoGames S.A (NASDAQ:NGMS) has partnered with BIG Brazil to enter Brazil's newly regulated iGaming market with the Caesars Brazil brand. This deal includes NeoGames providing its gaming platform, sportsbook solution, and other services to support BIG Brazil's ambition to become a leading operator in Brazil. The partnership follows BIG Brazil's licensing agreement with Caesars Entertainment for the Caesars brand in Brazil.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:06 pm